Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Ford

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cancer|July 1, 1989
Therapy: state-of-the-art assessment of quality. The National Cancer Institute perspectiveL G Ford
Progress in Clinical and Biological Research|January 1, 1989
Innovations in diffusionL G Ford
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Breast cancer prevention: results of the National Surgical Adjuvant Breast and Bowel Project (NSABP) breast cancer prevention trial (NSABP P-1: BCPT)B K Dunn, L G Ford
Progress in Clinical and Biological Research|January 1, 1997
Tamoxifen Breast Cancer Prevention Trial--an updateL G Ford, K A Johnson
The Breast Journal|July 27, 2001
From adjuvant therapy to breast cancer prevention: BCPT and STARB K Dunn, L G Ford
Cancer Detection and Prevention|January 1, 1990
Cancer control research for community programs: the National Cancer Institute initiativeC P Hunter, A R Bavier, L G Ford
Hematology/Oncology Clinics of North America|January 15, 1999
Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experienceB K Dunn, B S Kramer, L G Ford
Hospitals|August 1, 1976
Implications of PSROs for long-term careW F Jessee, L G Ford, J S Pebbutt
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Breast cancer prevention: the next stepsB K Dunn, W McCaskill-Stevens, L G Ford
JAMA|February 22, 1995
Estrogen replacement therapy in breast cancer survivorsJ A Perlman, K Johnson, S Nayfield, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cancer|July 1, 1989
Therapy: state-of-the-art assessment of quality. The National Cancer Institute perspectiveL G Ford
Progress in Clinical and Biological Research|January 1, 1989
Innovations in diffusionL G Ford
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Breast cancer prevention: results of the National Surgical Adjuvant Breast and Bowel Project (NSABP) breast cancer prevention trial (NSABP P-1: BCPT)B K Dunn, L G Ford
Progress in Clinical and Biological Research|January 1, 1997
Tamoxifen Breast Cancer Prevention Trial--an updateL G Ford, K A Johnson
The Breast Journal|July 27, 2001
From adjuvant therapy to breast cancer prevention: BCPT and STARB K Dunn, L G Ford
Cancer Detection and Prevention|January 1, 1990
Cancer control research for community programs: the National Cancer Institute initiativeC P Hunter, A R Bavier, L G Ford
Hematology/Oncology Clinics of North America|January 15, 1999
Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experienceB K Dunn, B S Kramer, L G Ford
Hospitals|August 1, 1976
Implications of PSROs for long-term careW F Jessee, L G Ford, J S Pebbutt
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Breast cancer prevention: the next stepsB K Dunn, W McCaskill-Stevens, L G Ford
JAMA|February 22, 1995
Estrogen replacement therapy in breast cancer survivorsJ A Perlman, K Johnson, S Nayfield, et al.
Pageof 3